Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 tesla: Should we use an endorectal coil?

Investigative Radiology

Volumn 46, Issue 5, 2011, Pages 301-306

  Yakar, Derya ^a   Heijmink, Stijn W T P J ^a   Hulsbergen Van De Kaa, Christina A ^a   Huisman, Henkjan ^a   Barentsz, Jelle O ^a   Fütterer, Jurgen J ^a   Scheenen, Tom W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

3 Tesla; endorectal coil; MR spectroscopic imaging; prostate cancer; prostate cancer localization

Indexed keywords

GLUCAGON; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDORECTAL COIL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TUMOR VOLUME;

EID: 79954824953     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3182007503     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Cooner WH, Mosley BR, Rutherford CL Jr, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990;143:1146-1152.
3. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol. 1994;151:1283-1290. (Pubitemid 24121936)
4. Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am J Roentgenol. 2000;174:623-627. (Pubitemid 30126236)
5. Rabbani F, Stroumbakis N, Kava BR, et al. Incidence and clinical significance of false-negative sextant biopsies of the prostate [in German]. Urologe A. 1998;37:660. (Pubitemid 128713389)
6. Partin AW, Carter HB, Chan DW, et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J Urol. 1990;143:747-752. (Pubitemid 20112095)
7. Scheidler J, Hricak H, Vigneron DB, et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology. 1999;213:473-480. (Pubitemid 29510595)
8. Futterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology. 2006;241:449-458. (Pubitemid 44632891)
9. Cheng LL, Wu C, Smith MR, et al. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. FEBS Lett 2001;494:112-116. (Pubitemid 32289382)
10. van der Graaf M, Schipper RG, Oosterhof GO, et al. Proton MR spectroscopy of prostatic tissue focused on the detection of spermine, a possible biomarker of malignant behavior in prostate cancer. MAGMA. 2000;10:153-159. (Pubitemid 30397433)
11. Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J Comput Assist Tomogr. 2006;30:7-11. (Pubitemid 43052291)
12. Kajihara H, Hayashida Y, Murakami R, et al. Usefulness of diffusion-weighted imaging in the localization of prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74:399-403.
13. Gibbs P, Liney GP, Pickles MD, et al. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Invest Radiol. 2009;44:572-576.
14. Yakar D, Hambrock T, Huisman H, et al. Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy. Invest Radiol. 2010;45: 121-125.
15. Heijmink SW, Futterer JJ, Hambrock T, et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology. 2007;244:184-195. (Pubitemid 46981973)
16. Hricak H, White S, Vigneron D, et al. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology. 1994;193:703-709. (Pubitemid 24366938)
17. Scheenen TW, Gambarota G, Weiland E, et al. Optimal timing for in vivo 1H-MR spectroscopic imaging of the human prostate at 3T. Magn Reson Med. 2005;53:1268-1274. (Pubitemid 40734645)
18. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004;233:701-708.
19. Scheenen TW, Heijmink SW, Roell SA, et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology. 2007;245:507-516. (Pubitemid 47612533)
20. Epstein JI, Walsh PC, Carmichael M, et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA. 1994;271:368-374. (Pubitemid 24037911)
21. Obuchowski NA, Lieber ML, Powell KA. Data analysis for detection and localization of multiple abnormalities with application to mammography. Acad Radiol. 2000;7:516-525. (Pubitemid 30432337)
22. Rutter CM. Bootstrap estimation of diagnostic accuracy with patient-clustered data. Acad Radiol. 2000;7:413-419. (Pubitemid 30341573)
23. Weinreb JC, Blume JD, Coakley FV, et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy- results of ACRIN prospective multi-institutional clinicopathologic study. Radiology. 2009;251:122-133.
24. White S, Hricak H, Forstner R, et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology. 1995;195:385-390.
25. Ikonen S, Kivisaari L, Vehmas T, et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol. 2001;42:70-73. (Pubitemid 33630131)